Sentences with phrase «private life sciences companies»
Previously serving in the General Counsel role for both public and private life sciences companies as well as the Compliance Officer and Corporate Secretary for a public company, Christina has broad strategic «in - house» experience, including extensive experience with intellectual property and partnership transactions, financings, patent portfolio development, compliance and other legal matters.
http://www.idri.org/
Led by OrbiMed Advisors, an investment management firm focused on the healthcare sector, Caduceus Private Investment funds invest primarily in US mid and late stage private life science companies and medical technologies.
Not exact matches
Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early - and mid-stage human healthcare and life science companies with a special focus on pharmaceuticals, diagnostics and medical devices.
With investments in more than 200 companies across 15 countries, Tavistock Group's investment portfolio includes: life sciences, sports teams and sporting events, manufacturing and distribution, oil, gas and energy, financial services, restaurants, commercial properties, private luxury residential properties, resort properties and master - planned real estate developments.
California hosts a range of life science employers: hundreds of biotechnology and pharmaceutical companies, state and private academic institutions, private research organizations, and government laboratories.
Finally, students need to be made more aware of the job opportunities available to them in the private sector, which can be accomplished through university - sponsored job fairs, guest lecturers from the life sciences industry, and visits to local biotechnology and pharmaceutical companies.
He has also served as a board member for numerous other private and public life science companies, including Achillion, Avanir Pharmaceuticals, Barrier Therapeutics, Biovitrum AB, CoTherix, InterMune, Pearl Therapeutics, Quatrx Pharmaceuticals, Rigel, and Sangstat.
Over his 35 - year career, John has held various Chairman, CEO, President and Board positions in public and private life - science companies.
He currently sits on the Board of Directors at Data Sciences International, a private life science technology company and at ALDA, the Life Sciences and Diagnostic Tools Associatlife science technology company and at ALDA, the Life Sciences and Diagnostic Tools AssociatLife Sciences and Diagnostic Tools Association.
Biotech Showcase ™, produced by Demy - Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences.
SVB Financial Group engages in the provision of diversified financial services to emerging, growth and established technology companies and the life science, cleantech, venture capital, private equity and premium wine markets.
Dave's experience includes start - up to Fortune 1000 companies, public and private companies, domestic and international, and includes experience in consumer and industrial markets, life science, pharmaceuticals and medical device companies, technology, real estate and banking and finance.
«These dedicated individuals are representative of our firm's core strengths in life sciences, venture capital and emerging companies, private equity, technology, M&A and healthcare,» said Foley Hoag co-managing partner Jeffrey Collins.
We represent public and private high - growth companies of all sizes in the technology, health care, life sciences, consumer products, media and medical devices industries.
Mr. Smith represents private companies in a broad range of industries and sectors, including venture capital, life sciences, software, internet, real estate, manufacturing, retail, telecommunications and energy (including oil and gas).
Our corporate attorneys represent clients in the biotechnology and life sciences industry regardless of whether those clients are not - for - profit entities, emerging companies or multi-million dollar private or public companies.